Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02999633 |
Title | Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia (ISLAY) |
Acronym | ISLAY |
Recruitment | Terminated |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Sanofi |
Indications | |
Therapies | |
Age Groups: | child | senior | adult |
Covered Countries | USA | LTU | ITA | HUN | FRA | FIN |